Nanoveu Secures $2.3M to Propel Edge AI, 3D Tech, and Solar Innovations

Capital Injection to Accelerate Nanoveu’s Technology Commercialisation

Nanoveu Limited (ASX: NVU), a Perth-based innovator in advanced semiconductor and materials science technologies, has secured firm commitments to raise $2.3 million through a share placement priced at 3.1 cents per share. The placement includes a 1-for-2 attaching option exercisable at 4.5 cents within two years, underscoring investor confidence in the company’s growth trajectory.

Significantly, Nanoveu’s Executive Chairman, Dr David Pevcic, has committed to participate in the placement to the tune of $400,000, pending shareholder approval. This insider participation signals strong leadership conviction in the company’s strategic direction and upcoming milestones.

Targeted Investment Across Three High-Growth Divisions

The capital raised will be strategically deployed to accelerate commercialisation efforts across Nanoveu’s three core divisions. The EMASS platform, an ultra-low-power edge AI semiconductor technology, has demonstrated remarkable energy efficiency gains, up to 287 times better than existing systems, positioning it well to capture emerging opportunities in edge computing and AI-driven IoT devices.

Meanwhile, the EyeFly3D™ glasses-free 3D visualisation platform is gaining commercial traction, supported by initial orders and a multi-year Heads of Agreement with Rahum Nano Tech. This technology aims to disrupt traditional 3D display markets by eliminating the need for glasses, enhancing user experience across multiple device categories.

Nanoshield™ Solar coatings are undergoing field trials in Morocco and the UAE, testing their ability to reduce soiling and improve solar panel efficiency under real-world conditions. Positive outcomes here could open doors to the rapidly expanding renewable energy sector, where incremental efficiency gains translate into significant economic and environmental benefits.

Strengthened Balance Sheet and Market Position

The placement was managed by Evolution Capital and 62 Capital, who will receive a 6% fee and options as part of their remuneration. The issue price represents a discount to recent trading prices, a common feature in capital raises aimed at attracting sophisticated investors swiftly.

With the funds secured, Nanoveu is poised to accelerate its global expansion plans, leveraging a strengthened balance sheet to engage strategic partners and scale commercial operations. The company’s leadership team has been bolstered with global semiconductor and sales expertise, reflecting a clear intent to transition from development to revenue generation.

Dr Pevcic highlighted the company’s momentum, stating, “We have a world-class team and growing commercial momentum and look forward to updating our supporters on our progress in the near future.”

Looking Ahead

Shareholder approval for the Chairman’s participation and director-related shares is expected at a general meeting scheduled for July 2025. Meanwhile, investors will be watching closely for updates on the Nanoshield™ Solar field trials and commercial milestones from EMASS and EyeFly3D™ as indicators of Nanoveu’s ability to convert innovation into sustainable growth.